Procognia
Latest round
- Series A
Last raised
- Sep 2000
Total raised
- $2.5M
Investors
- 2
About Procognia
Procognia Ltd is a renowned leader in the growing field of glycobiology, specifically in glycoanalysis. Publicly traded on the TASE (symbol: PRCG), Procognia is recognized for its state-of-the-art proprietary tools and high end platforms, providing fast and accurate glycoanalysis of glycoproteins.
Who invested in Procognia
2 investors across 1 round
See all investors in Procognia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 11, 2000
Amount
$2.5M
Investors
Questions about Procognia
Who invested in Procognia?
Procognia has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Procognia raised?
Procognia has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Procognia last raise money?
Procognia's most recent round on record is a Series A, in Sep 2000.
What does Procognia do?
Procognia Ltd is a renowned leader in the growing field of glycobiology, specifically in glycoanalysis.
Where is Procognia headquartered?
Procognia is headquartered in Ashdod, Israel.
Which VCs invest in companies like Procognia?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Procognia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Procognia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.